1-8 of 8
Emily K Dolezal
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Mutation Profiling of Therapy-Related Myeloid Neoplasms Using Next-Generation Sequencing Demonstrates Distinct Profiles from De Novo Disease

Alan H. Shih, MDPhD, Franck Rapaport, PhD, Stephen S. Chung, MD, Emily K Dolezal, Sean Hobson, MA, Mary K Amato, Christopher Y. Park, MD PhD, Mikkael A. Sekeres, MD MS, Marcel R.M. van den Brink, MD PhD, Stephen Nimer, MD, Ross L. Levine, MD, Jaroslaw P. Maciejewski, MD PhD, Virginia M. Klimek, MD
Journal: Blood
Blood (2014) 124 (21): 4611.
https://doi.org/10.1182/blood.V124.21.4611.4611
Published: 2014
Journal Articles

Comprehensive Mutational Profiling In Myelodysplastic Syndromes Treated With Decitabine and Tretinoin

Alan H. Shih, MD PhD, Sean M. Devlin, PhD, Emily K. Dolezal, Kristina M. Knapp, BS, Kai Wang, MD PhD, Eric M. Sanford, BS, Tim Brennan, PhD, Roman Yelensky, PhD, Michelle Nahas, PhD, Geoff A Otto, PhD, Doron Lipson, PhD, Philip J Stephens, PhD, Vincent Miller, MD, Marcel R.M. van den Brink, MD, PhD, Ross L. Levine, MD, Stephen Nimer, MD, Virginia M. Klimek, M.D
Journal: Blood
Blood (2013) 122 (21): 2791.
https://doi.org/10.1182/blood.V122.21.2791.2791
Published: 2013
Journal Articles

An iPSC-Based Model Of MDS For Phenotype-Driven Gene and Drug Discovery

Ibrahim Boussaad, PhD, Andriana Kotini, PhD, Emily K Dolezal, Stephen Nimer, MD, Eirini P Papapetrou, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 859.
https://doi.org/10.1182/blood.V122.21.859.859
Published: 2013
Journal Articles

IPS Cells From Del(7q)-MDS Patients Display Impaired Proliferation and Hematopoietic Commitment

Ibrahim Boussaad, PhD, Emily K Dolezal, Fabiana Perna, MD, Stephen D Nimer, MD, Eirini P Papapetrou, MD, PhD
Journal: Blood
Blood (2012) 120 (21): 174.
https://doi.org/10.1182/blood.V120.21.174.174
Published: 2012
Journal Articles

Phase 2 Study of Decitabine in Combination with Tretinoin in Myelodysplastic Syndromes and Acute Myelogenous Leukemia: Interim Results

Virginia M. Klimek, M.D., Emily K Dolezal, Joseph G. Jurcic, MD, Sean Devlin, PhD, Kevin Zikaras, BS, Jae H. Park, MD, Todd L. Rosenblat, MD, Stephen Nimer, MD
Journal: Blood
Blood (2012) 120 (21): 3815.
https://doi.org/10.1182/blood.V120.21.3815.3815
Published: 2012
Journal Articles

Maitake Mushroom Extract in Myelodysplastic Syndrome (MDS): A Phase II Study

Kathleen M. Wesa, MD, Virginia M. Klimek, M.D., Susanna Cunningham-Rundles, PhD, Allison Hirsch, Emily K. Dolezal, Gria N Jacobs, Marci I Coleton, MA, Stephen D. Nimer, MD, Barrie R. Cassileth, PhD
Journal: Blood
Blood (2011) 118 (21): 5043.
https://doi.org/10.1182/blood.V118.21.5043.5043
Published: 2011
Journal Articles

Mutational Analysis of Therapy-Related MDS/AML

Alan H. Shih, MD, PhD, Stephen S. Chung, MD, Emily K. Dolezal, Su-Jiang Zhang, MD, Omar Abdel-Wahab, MD, Christopher Y. Park, MD, PhD, Stephen D. Nimer, MD, Ross L Levine, MD, Virginia M. Klimek, M.D.
Journal: Blood
Blood (2011) 118 (21): 2802.
https://doi.org/10.1182/blood.V118.21.2802.2802
Published: 2011
Journal Articles

Clinical Activity of DNA Methyltransferase Inhibitors In Therapy-Related Myelodysplastic Syndromes: A Retrospective Study

Michael T Tees, M.D., Emily K. Dolezal, Stephen D. Nimer, M.D., Virginia M. Klimek, M.D.
Journal: Blood
Blood (2010) 116 (21): 1891.
https://doi.org/10.1182/blood.V116.21.1891.1891
Published: 2010